EP2361617
Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.4.2005EP published:
11.6.2014EP application number:
11161473.1
EPO information:
European Patent Register
Max expiry date:
20.4.2025
Title:
Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
Timeline
Today
21.4.2005EP application
11.6.2014EP Publication
Owner
Name:
ALLERGAN, INC.Address:
2525 Dupont Drive, 92612, Irvine CA, US
Inventor
Name:
Huang, Glenn T.Address:
Fremont, CA, US
Name:
Nivaggioli, ThierryAddress:
Atherton, CA, US
Priority
Number:
836880Date:
30.4.2004Country:
US
Classification
Categories:
A61K 9/70